美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
符合检索条件的记录共14
2 页 当前第 1 页  下一页 最后一页 返回检索页
1药品名称BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
申请号091149产品号001
活性成分BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET;SUBLINGUAL规格EQ 2MG BASE;EQ 0.5MG BASE
治疗等效代码AB参比药物
批准日期2014/09/08申请机构TEVA PHARMACEUTICALS USA
2药品名称BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
申请号091149产品号002
活性成分BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET;SUBLINGUAL规格EQ 8MG BASE;EQ 2MG BASE
治疗等效代码AB参比药物
批准日期2014/09/08申请机构TEVA PHARMACEUTICALS USA
3药品名称BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
申请号091422产品号001
活性成分BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET;SUBLINGUAL规格EQ 2MG BASE;EQ 0.5MG BASE
治疗等效代码AB参比药物
批准日期2013/02/22申请机构ACTAVIS ELIZABETH LLC
4药品名称BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
申请号091422产品号002
活性成分BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET;SUBLINGUAL规格EQ 8MG BASE;EQ 2MG BASE
治疗等效代码AB参比药物
批准日期2013/02/22申请机构ACTAVIS ELIZABETH LLC
5药品名称BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
申请号201633产品号001
活性成分BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET;SUBLINGUAL规格EQ 2MG BASE;EQ 0.5MG BASE
治疗等效代码AB参比药物
批准日期2016/08/05申请机构SUN PHARMACEUTICAL INDUSTRIES LTD
6药品名称BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
申请号201633产品号002
活性成分BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET;SUBLINGUAL规格EQ 8MG BASE;EQ 2MG BASE
治疗等效代码AB参比药物
批准日期2016/08/05申请机构SUN PHARMACEUTICAL INDUSTRIES LTD
7药品名称BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
申请号203136产品号001
活性成分BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET;SUBLINGUAL规格EQ 2MG BASE;EQ 0.5MG BASE
治疗等效代码AB参比药物
批准日期2013/02/22申请机构AMNEAL PHARMACEUTICALS
8药品名称BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
申请号203136产品号002
活性成分BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET;SUBLINGUAL规格EQ 8MG BASE;EQ 2MG BASE
治疗等效代码AB参比药物
批准日期2013/02/22申请机构AMNEAL PHARMACEUTICALS
9药品名称BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
申请号203326产品号001
活性成分BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET;SUBLINGUAL规格EQ 2MG BASE;EQ 0.5MG BASE
治疗等效代码AB参比药物
批准日期2014/06/27申请机构ROXANE LABORATORIES INC
10药品名称BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
申请号203326产品号002
活性成分BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET;SUBLINGUAL规格EQ 8MG BASE;EQ 2MG BASE
治疗等效代码AB参比药物
批准日期2014/06/27申请机构ROXANE LABORATORIES INC